Amgen Releases 5th Annual Biosimilars Report

May 15, 2018
By Pharmaceutical Executive Editors

Amgen, the independent biotech company, announced its fifth annual trends in biosimilars report, developed alongside Xcenda. The report highlights current trends and brings to light future considerations that will be critical for manufacturers, distributors, payers, and prescribers to consider in order to maximize access to this new product category.

View the report here.

 

native1_300x100
lorem ipsum